Alexandrovich Alexey Vinogradov Net Worth & Insider Trades

Alexandrovich Alexey Vinogradov - Director, Argos Therapeutics Inc

As of April 4, 2016

What is Alexandrovich Alexey Vinogradov's Net Worth?

The current estimated net worth of Argos Therapeutics Inc's Director, Alexandrovich Alexey Vinogradov, is estimated to be about $0 . Alexandrovich Alexey Vinogradov owns about 2,000 units of Argos Therapeutics Inc common stock. In the last 2 years at Argos Therapeutics Inc, Alexandrovich Alexey Vinogradov has sold an estimated value of $0 worth.

What is Alexandrovich Alexey Vinogradov's Past Insider Trading?

Alexandrovich Alexey Vinogradov's largest purchase order was 2,000 units , worth over $4.3K on December 16, 2015. In total, Alexandrovich Alexey Vinogradov has made about 4 transactions over 2 years of their time at Argos Therapeutics Inc. Alexandrovich Alexey Vinogradov usually trades in December, March, April and June, with the busiest year in 2015.

Alexandrovich Alexey Vinogradov

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Alexandrovich Alexey Vinogradov's' Mailing Address?

  • Mailing address is C/o Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704 NC

Argos Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Jeffrey D. Abbey 2016 $450,000 $356,500 $1,029,892 $26,477 $1,862,869
Jeffrey D. Abbey 2015 $450,000 $202,500 $714,502 $14,861 $1,381,863
Charles A Nicolette, Ph.D. 2016 $325,000 $121,875 $720,925 $18,669 $1,186,469
Charles A Nicolette, Ph.D. 2015 $325,000 $108,875 $446,564 $17,217 $897,656
Lee F. Allen, M.D., Ph.D. 2016 $407,292 $389,375 $1,016,592 $70,120 $1,883,379
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1105533/000117184317003980/def14a_070617.htm

What are Argos Therapeutics Inc's Past Insider Trades?

Argos Therapeutics Inc's most recent insider trade came on January 12, 2018 by Lori R Harrelson who sold 64,329 units worth $10.59K . In the last 4 years, insiders at Argos Therapeutics Inc have sold an estimated value of $79.34M and bought an estimated value of $13.75M worth of shares. Insider trading is most common in January, with the busiest year in 2016. The most active traders at the company are Jeffrey Abbey, Chief Executive Officer,  Pharmstandard Co Stock Joint,  and Sa International Pharmstandard .

ARGOS THERAPEUTICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1